Drugs / HAV Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03525119 | May → Oct 2018 | — | Takeda | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HAV Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03525119 ↗ |
| Modality | Vaccine | “an inactivated hepatitis a (HAV) virus vaccine” PMID 36681529 ↗ Jan 2023 |
| Route | Intramuscular | “HAV Vaccine IM injection.” NCT03525119 ↗ |